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ABSTRACT 
To investigate the characteristic features of high density lipoproteins in type 2 diabetes mellitus patients, we 
examined the lipid parameters, quantitated glucose and insulin levels along with the apolipoprotein ratios. Using 
radial immunodiffusion, colorimetric, flourimetric and ultracentrifugation methods the values of the parameters 
were obtained. We observed a moderate elevation of the Hdl/Ldl cholesterol and apolipoprotein A-1/A-11 ratio 
which are exponents risk factors in the exacerbation of atherosclerosis. Both males and females show higher 
level of these parameters when compared with controls and were markedly higher (p>0.05). We also noticed a 
marked elevated correlation (r=0.891, p<0.01) between the high density lipoprotein and the apoprotein A-1/A-11 
ratio. Understanding that Hdl of diabetic patients are enriched with triglyceride and cholesterol depleted we 
reason that changes that may occur as a result of poor management of diabetes has the ability to decrease the 
antiatherogenic effect of high density lipoprotein. We could advance evidence that an elevated apolipoprotein A-
1/A-11 ratio in type 2 diabetic patients has the capacity to inhibit the development of atherosclerosis. 
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INTRODUCTION 
For lipids to perform their metabolic functions effectively in tissues and organs, they must be transported. This 
transport is effectuated by micelles called lipoproteins. Atherosclerosis which is a complication of diabetes has 
elicited major health concern. A vascular disease accounting for over 70% of diabetic mortality and morbidity, it 
is now known to be a complication of type 2 diabetes mellitus. Previous studies gleamed from periodicals opines 
that the incidence and prevalence of atherosclerosis are inversely correlated with the level of plasma high density 
lipoprotein (Hdl) [1,20]. It is yet not clear if a similar scenario is presented for type 1 diabetes. The triad of 
artherosclerosis, type 2 diabetes mellitus and cardiovascular disease requires further consideration in developing 
therapies. High density lipoprotein (Hdl) plays diverse roles in cholesterol transport, exuding vascular-
protection, and elucidating endothelium related vaso-relaxation, antioxidation, anti-inflamatory as well as anti-
thrombotic functions [2,24]. There is now enough evidence to input that a strong relationship exist between the 
severity of type 2 diabetes and an enervated Hdl and apoprotien A-1 and A-11 functionality [3]. Studies has 
shown that in combination with Hdl cooperativity exist with sphingosine-1-phosphate (SIP) to express their 
biological function [4]. SIP is known to be a facilitator of the protective effect of Hdl including the ability to 
inhibit reverse atherosclerosis. Studies have pointed in a direction which elucidated the fact that atherosclerosis 
is a multifactorial inflammatory disease in which protanoids and cyclooxygenase play diverse roles to enhance 
the disease process [5]. It is now known that SIP combines with Hdl exhibiting synergistic function in induction 
of the Cox-2 expression and prostaglandin 1-2 release [6]. 
There is evidence to show that in type 2 DM, the capacity of the Hdl playing a protective function is impaired 
[7,22,23]
. The need to re-evaluate the biochemical components of Hdl and other lipids in terms of structure and 
function using more advance techniques like nuclear magnetic resonance to increase understanding is 
encouraged. 
MATERIALS AND METHOD 
At the Federal Medical centre, Yenagoa, Bayelsa State, Nigeria, blood (serum, plasma) and urine samples were 
collected from type 2 diabetic patients (n=60), from (males=30) and (females=30). Blood glucose levels of 
subjects were above threshold value > 10mmol/l with presence of glucosuria and ketonuria. Control subjects for 
the experiment were those with normal glucose levels ranging between 3.5-6.7 mmol/l with no glucosuria and 
ketone in urine. All samples were over night fasting samples. 
ANALYTICAL METHODS 
The concentration of fasting blood glucose was determined by the glucose oxidase method with the use of 
Randox Kits (London) and values measured with a spectrophotometer SPEC22D+ set at 540nm. Urine samples 
were analysed with N-multistix Macherry-Nagel (Germany) for glucose and ketones. 
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Triglyceride and cholesterol were determined colorimetrically with Corning colorimeter. Cholesterol was 
measured by a Lieberman Burchard reagent method. The trigyceride were determined by a flourimetric 24 
pentanedione procedure calibrated with inolein. 
HDL cholesterol was determined by measurement of cholesterol in the supernatant after precipitation of VLDL 
and LDL in 2.0ml of plasma with 0.15ml of 1M MnCl2 and 0.12ml of sodium Heparin (35mg/ml, Ricker) [19, 
8,21]. The LDL cholesterol was derived from the Friedewald equations as follows: LDLcholesterol = total 
cholesterol-(HLD Cholesterol+Triglyceride/5). 
Plasma Apo A-1 and A-11 were determined by radial immunodiffusion assay. 
Serum insulin levels were measured using electrochemical illuminescence immunoassay (Poch Diagnostics, 
Manhein Germany). 
RESULTS 
Mean values of the various parameters estimated for males and females are shown in table 1 and 2 respectively. 
The data (mean + SD) are presented here for all 60 subjects and 60 normal (control). The data show that there 
was not much variation in the lipoprotein subclass in comparing the two groups. There was however a slight 
increase in A-1 in female than in males. We also noted that the degree of hyperglycemia also reflects the lipid 
levels. 
Table 1: Apolipoprotein and other lipids levels in Type 2 Diabetic Patients (Males) 
Parameters Control  
(n=30) 
Diabetics (n=30) p-value >0.05 
FBG (mmol/l) 4.8+1.5 15.8+3.0  
Insulin (Pmol/l) 125+5.0 145+3.10  
Triglyceride (mmol/l) 1.5+0.3 1.7+0.3  
Cholesterol (mmol/l) 4.3+1.5 6.8+0.8  
LDL Chol. (mmol/l) 3.35+1.2 5.7+3.06  
HDL chol. (mmol/l) 0.40+0.2 0.6+0.22  
HDLC/LDLC 0.12+0.01 0.10+0.01  
APO A-1 (g/l) 1.53+0.8 1.8+0.5  
APO A-11(g/l) 0.52+0.05 0.7+0.03  
A-1/A-11(g/l) 2.8+0.2 3.2+0.03  
Urine glucose Nil  ++  
Urine ketones Nil ++  
Values mean + SD 
 
Table 2: Apolipoprotein and other lipids level in type 2 Diabetic Patients (Females) 
Parameters Control  
(n=30) 
Diabetics (n=30) p-value >0.05 
FBG (mmol/l) 4.6+1.4 14.8+4  
Insulin (pmol/l) 124+6 140+3.2  
Triglyceride (mmol/l) 1.4+0.2 1.6+0.2  
Cholesterol (mmol/l) 4.5+1.6 6.7+0.4  
LDL Chol. (mmol/l) 3.4+1.3 5.6+3.04  
HDL chol. (mmol/l) 0.4+0.3 0.52+0.6  
HDLC/LDLC 0.11+0.01 0.09+0.01  
APO A-1 (g/l) 1.82+0.7 2.0+0.5  
APO A-11(g/l) 0.50+0.04 0.8+0.03  
A-1/A-11(g/l) 3.0+0.3 3.6+0.04  
Urine sugar Nil ++  
Urine ketones Nil ++  
Values are mean + SD 
DISCUSSION 
We have assessed the roles high density lipoprotein can play in type 2 diabetes mellitus. Using parameters such 
as glucose, insulin, lipids and the apolipoproteins, the present data suggest that hyperglycemia can be a 
predisposing factor modulating high density lipoprotein characteristics. The value of HDL/LDL cholesterol and 
apolipoprotein A-1/A-11 were higher in both males and females when compared with controls. Evidence shown 
by [8] elucidates this fact. The value of Apo A-1 was moderately higher for females as shown by this study. The 
difference in the Apo A-1/A-11 ratio for the diabetic patients and controls confer greater understanding. As 
shown by [6,9] there is significant correlation between the Apo A-1/A-11 ratio and the amount of high density 
lipoprotein. Among the subclass of Hdl, Hdl2, has been used to provide indirect evidence for reduced risk of 
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atherosclerosis. One can adduce possible biochemical mechanism which may be responsible for changes in high 
density lipoprotein particles. Insulin is known to modify APOA-11 release [10,18] and in condition of deficiency 
caused by type 2 diabetes, APOA-11 metabolism can be effected. It has been shown that insulin resistance has 
effect on lipoprotein subclass production and distribution. Evidence elucidates the fact that elevated insulin 
sensitivity has the potential to increase mean particle size of VLDL and reduce LDL and HDL particles. 
Previous studies have also shown that there is a shift in production of LDL and HDL in favour of LDL although 
a modest increase in small HDL is noticed [11,12]. Lipoprotein production in favour of Ldl and as it occurs in 
insulin resistance is a major predisposing factor in artherosclesrosis. It would appear that the lipoprotein subclass 
changes that occur in type 2 diabetes can be as a resistance. It is now known that HDL is a major carrier of 
sphingosine-1-phosphate which control major biological activities [13,14,15]. In diabetes HDL acting in tandem 
with SIP has the potential to improve vascular system function [16,17]. Additionally SIP modulates the production 
of cyclooxygenase.  
We have demonstrated that basically all major lipoprotein classes are affected as a function of insulin sensitivity 
in type 2 diabetes mellitus. Development of methods that will quantitate all subclasses of HDL will improve 
understanding and promote therapies that will enhance management of diabetes. 
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